Next Article in Journal
Cytotoxicity and Structure-Activity Relationships of Xanthone Derivatives from Mesua beccariana, Mesua ferrea and Mesua congestiflora towards Nine Human Cancer Cell Lines
Previous Article in Journal
Biohybrid -Se-S- Coupling Reactions of an Amino Acid Derived Seleninate
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 18
Issue 2
10.3390/molecules18021973
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Characterization of Novel Unsymmetrical and Symmetrical 3-Halo- or 3-Methoxy-substituted 2-Dibenzoylamino-1,4-naphthoquinone Derivatives

by
Yakini Brandy
1,
Nailah Brandy
1,
Emmanuel Akinboye
1,
Malik Lewis
1,
Claudia Mouamba
1,
Seshat Mack
1,
Ray J. Butcher
1,
Alan J. Anderson
2 and
Oladapo Bakare
1,*
1
Department of Chemistry, Howard University, Washington, DC 20059, USA
2
Department of Natural Sciences, Bowie State University, Bowie, MD 20715, USA
*
Author to whom correspondence should be addressed.
Molecules 2013, 18(2), 1973-1984; https://doi.org/10.3390/molecules18021973
Submission received: 31 December 2012 / Revised: 30 January 2013 / Accepted: 30 January 2013 / Published: 4 February 2013
(This article belongs to the Section Organic Chemistry)
Browse Figures
Versions Notes

Abstract

:
Symmetrical and unsymmetrical 3-halo- or 3-methoxy- substituted 2-dibenzoylamino-1,4-naphthoquinone analogs were synthesized with an average yield of 45% via sodium hydride promoted bis-acylation of 2-amino-3-chloro-1,4-naphthoquinone, 2-amino-3-bromo-1,4-naphthoquinone and 2-amino-3-methoxy-1,4-naphthoquinone.

Graphical Abstract

1. Introduction

The quinone moiety is an important part of many biologically active natural products and their synthetic analogs [1,2,3,4,5,6,7,8,9,10,11,12,13,14]. The quinonoid anti-cancer drugs such as mitomycin C, daunorubicin,doxorubicin and mitoxantrone have been used in the treatment of various types of cancers, including solid tumors, for many years. We have been involved in the synthesis and biological evaluation of some quinonoid compounds [15,16,17,18,19,20,21], and previously we developed 2-chloro-3-(N-succinimidyl)-1,4-naphthoquinone and some of its analogs as MEK1 specific inhibitors of the Ras-MAPK pathway [15]. In a subsequent report, we demonstrated the anti-carcinogenic activities of some of these imido-substituted 2-chloro-1,4-naphthoquinone derivatives on androgen-dependent, LNCaP, and androgen-independent, PC3 and DU145, human prostate cancer cell lines [16]. In continuation of our work on the development of novel imido-substituted 1,4-naphthoquinones for studies in our prostate and breast cancer drug development program, we have designed some novel bis-arylimido-substituted 1,4-naphthoquinones. The sodium hydride promoted bis-acylation of 2-amino-3-halo-1,4-naphthoquinone and 2-amino-3-methoxy-1,4-naphthoquinone to furnish some novel 3-halo- and 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone analogs is therefore reported here.

2. Results and Discussion

In our ongoing studies on the chemical modification of naphthoquinones to give biologically useful compounds, we previously reported the synthesis of some cyclic and acyclic imido-2-chloro-1,4-naphthoquinones obtained by reacting 2-amino-3-chloro-1,4-naphthoquinone with acid chlorides at elevated temperatures in the absence of a base or catalyst. Similar reaction conditions did not produce the corresponding bis-arylimido-1,4-naphthoquinone analogs in any appreciable yield. Hence, we explored a base promoted bis-acylation of the starting 2-amino-3-chloro-1,4-naphthoquinone. Various organic and inorganic bases were initially employed (including triethylamine, pyridine, DMAP and Na2CO3) at room temperature and at elevated temperatures. These conditions did not afford the target imido compounds, rather, the starting 2-amino-3-chloro-1,4-naphthquinone and the amide derivatives were mostly recovered. However, the reaction of 2-amino-3-chloro-1,4-naphthoquinone (1a) with sodium hydride in dry THF under an inert atmosphere, followed by a nucleophilic acyl substitution reaction of the resulting nucleophile on an appropriate acid chloride furnished imido-substituted derivatives in addition to the amide analogs, as shown in Scheme 1.
Molecules 18 01973 g004 550
Scheme 1. Synthesis of symmetrical 3-halo- and 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone analogs.
Scheme 1. Synthesis of symmetrical 3-halo- and 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone analogs.
Molecules 18 01973 g004
Similar reaction on 2-amino-3-bromo-1,4-naphthquinone (1b) and 2-amino-3-methoxy-1,4-naphthoquinone (1c) also furnished the corresponding imido-substituted derivatives, showing the procedure proceeded equally well in the presence of either electron withdrawing or electron donating group at position 3. The target imido-substituted analogs 3a–u were obtained with an average yield of 45% after purification by column chromatography on silica gel and/or recrystallization from appropriate solvents.
The 2-amino-3-halo-1,4-naphthoquinones 1a,b were prepared from the 2,3-dichloro-1,4-naphtho-quinone as previously described for 1a [15]. An initial attempt to obtain 1c from 2-chloro-3-methoxy-1,4-naphthoquinone furnished the amino-chloro analog 1a instead. This suggested substitution of the methoxy group rather than the chloro group, which is most likely due to lower electrophilicity of C2 as a result of electron delocalization from the methoxy group at C3 as shown in Figure 1. Consequently, we first synthesized 2,3-dimethoxy-1,4-naphthoquinone (2) from 2,3-dichloro-1,4-naphthoquinone and sodium methoxide in 72% yield as shown in Scheme 2 [22]. Subsequent reaction of 2 with ammonia in the presence of ammonium carbonate furnished 2-amino-3-methoxy-1,4-naphthoquinone (1c) in 52% yield (Scheme 2). The structures of all the symmetrical imido-substituted 1,4-naphthoquinones 3a–u synthesized in this study are shown in Figure 2.
Molecules 18 01973 g001 550
Figure 1. Delocalization of electrons from the methoxy group on C-3 reduces the electrophilicity of C2.
Figure 1. Delocalization of electrons from the methoxy group on C-3 reduces the electrophilicity of C2.
Molecules 18 01973 g001
Molecules 18 01973 g005 550
Scheme 2. Synthesis of 2-amino-3-methoxy-1,4-naphthoquinone.
Scheme 2. Synthesis of 2-amino-3-methoxy-1,4-naphthoquinone.
Molecules 18 01973 g005
Molecules 18 01973 g002 550
Figure 2. Structures of 3-halo- or 3-methoxy-substituted 2-dibenzoyl-amino-1,4-naphthoquinone analogs.
Figure 2. Structures of 3-halo- or 3-methoxy-substituted 2-dibenzoyl-amino-1,4-naphthoquinone analogs.
Molecules 18 01973 g002
Two unsymmetrical analogs 5 and 7 were also synthesized as shown in Scheme 3 by first forming the amide derivatives 4 and 6. The amide derivative 4 was made by heating 2-amino-3-chloro-1,4-naphthoquinone in p-chlorobenzoyl chloride; or by stirring 2-amino-3-chloro-1,4-naphthoquinone, sodium hydride and p-chlorobenzoyl chloride (1:3:1.5 mole ratio) in THF for 5 min at room temperature. Amide 6 was synthesized in excess acetic anhydride at room temperature with a catalytic amount of conc. sulfuric acid [23]. Subsequent reaction of the isolated pure amides, 4 and 6, with NaH followed by addition of benzoyl chloride (1:2:2 mole ratio) or p-chlorobenzoyl chloride (1:1.5:1.3 mole ratio) furnished the unsymmetrical analogs 5 and 7 in 43% and 41 % yield, respectively.
Molecules 18 01973 g006 550
Scheme 3. Synthesis of unsymmetrical 2-N-benzoyl-N-(4-chlorobenzoyl)amino-3-chloro-1,4-naphthoquinone (5) and 2-N-acetyl-N-(4-chlorobenzoyl)amino-3-chloro-1,4-naphthoquinone (7) analogs.
Scheme 3. Synthesis of unsymmetrical 2-N-benzoyl-N-(4-chlorobenzoyl)amino-3-chloro-1,4-naphthoquinone (5) and 2-N-acetyl-N-(4-chlorobenzoyl)amino-3-chloro-1,4-naphthoquinone (7) analogs.
Molecules 18 01973 g006
As shown in Figure 3, the crystal structure of compound 7 shows that the imide group is almost perpendicular to the plane of the naphthoquinone ring and the two imide carbonyls are anti to each other.
Molecules 18 01973 g003 550
Figure 3. Molecular structure of compound 7.
Figure 3. Molecular structure of compound 7.
Molecules 18 01973 g003

3. Experimental

3.1. General

Infrared spectra were recorded on a Perkin Elmer PR 100 Spectrometer equipped with an Attenuated Total Reflectance (ATR) window. 1H- and 13C-NMRs were performed on the Bruker Avance 400 MHZ spectrometer. Compounds were analyzed in deuterated chloroform (CDCl3), deuterated dimethyl sulfoxide (DMSO-d6). Mass spectra were obtained on a Jeol AccuTOF-CS ESI TOF, LTQ Orbitrap XL tandem Mass Spectrometer and Agilent Technologies 6224 TOF LC MS. Unless where specified, all materials were obtained from commercial sources and used without further purification.
2-Amino-3-methoxy-1,4-naphthoquinone (1c). Ammonia gas was bubbled continuously into a mixture of 2,3-dimethoxy-1,4-naphthoquinone (2, 0.305 mg, 1.40 mmol) and (NH4)2CO3 (439 mg, 4.57 mmol) in anhydrous MeOH (70 mL). The reaction mixture was refluxed at 50 °C for 2 h. Additional (NH4)2CO3 (418 mg, 4.35 mmol) was added to the cooled solution and the mixture was again refluxed for 1 h. Nitrogen was bubbled through the cooled solution for 10 mins. The solution was concentrated in vacuo, ice-cold water (20 mL) added to the resulting mixture, and the precipitate formed was isolated by filtration under suction. This solid was air dried to obtain a red solid (226 mg) which was re-crystallized from ethyl acetate / hexane (50:50) to obtain red solid (148 mg, 52%). Mp: 138–140 °C. IR (cm−1) 3425, 3313, 3246, 2948, 1670, 1638, 1607, 1579, 1564, 1352, 1221. 1H-NMR (CDCl3) 4.00 (s, 3H), 5.08 (s, 2H), 7.54–7.58 (dt, 1H, J = 1.28, 7.48 Hz), 7.63–7.67 (dt, 1H, J = 1.44, 7.56 Hz), 7.93–7.96 (dd, 1H, J = 1.32, 7.60 Hz), 8.00–8.03 (dd, 1H, J = 1.00, 7.64 Hz). 13C-NMR (CDCl3) 59.92, 125.31, 125.55, 129.74, 131.70, 131.83, 133.88, 137.06, 138.51, 177.95, 181.57. ESI HRMS m/z 204.0650 ([M + H]+ calcd 204.0661).
2,3-Dimethoxy-1,4-naphthoquinone (2). A mixture of 2,3-dichloro-1,4-naphthoquinone (4.960 g, 0.022 mol) and sodium methoxide (3.582 g, 0.066 mol) in anhydrous MeOH (100 mL) was refluxed for 5 h. A second portion of sodium methoxide (2.365 g, 0.044 mol) was added and the mixture refluxed for another hour. The reaction mixture was concentrated under vacuum, filtered and the residue repeatedly washed with cold water to obtain a yellow solid (3.463 g, 72%). Mp: 113–115 °C. IR (cm−1) 3014, 2957, 1673, 1651, 1590, 1320, 1268, 1211.66, 1162, 1043, 1015. 1H-NMR (CDCl3) 4.11 (s, 6H), 7.67–7.72 (m, 2H), 8.03–8.08 (m, 2H). 13C-NMR (CDCl3) 61.39, 126.21, 130.81, 133.70, 147.54, 181.93. ESI HRMS m/z 241.0470 ([M+Na]+ calcd 241.0477).

3.2. General Experimental for the Imido-Substituted Derivatives 3a–u

2-Amino-3-chloro-1,4-naphthoquinone, 2-amino-3-bromo-1,4-naphthoquinone or 2-amino-3-methoxy-1,4-naphthoquinone was dissolved in freshly distilled THF (15 mL). NaH was added and the mixture was stirred at room temperature for 15 min. The appropriate acid chloride was added, drop wise, and the mixture was stirred for 24 hours under argon (mole ratio of substrate:NaH:acid chloride = 1:2.3:2.3). THF was evaporated under vacuum and the mixture was washed with ice-water (10 g ice and 10 mL water). The ice-water mixture was extracted with CH2Cl2 (30 mL, 20 mL consecutively). The combined organic phase was washed with water (3 × 20 mL), saturated NaCl solution (3 × 20 mL), and then dried over anhydrous MgSO4. The crude material was purified via triturating in hot ethanol, recrystallization in ethyl acetate and/or via column chromatography.

Characterization Data for Each Isolated Imido-Substituted Compounds 3a–u

2-Dibenzoylamino-3-chloro-1,4-naphthoquinone (3a). Yellow solid. (61%). Mp: 294–297 °C. IR (cm−1) 3328, 1698, 1672, 1618, 1590, 1573. 1H-NMR (DMSO-d6) 7.35–7.39 (t, 4H, J = 7.5 Hz), 7.46–7.50 (tt, 2H, J = 1.2, 7.5 Hz), 7.65–7.67 (m, 4H), 7.83–7.90 (m, 2H), 7.94–7.96 (dd, 1H, J = 1.7, 7.4 Hz), 8.04–8.06 (dd, 1H, J = 1.3, 8.2 Hz). 13C-NMR (CDCl3) 127.61, 127.64, 128.59, 129.11, 130.69, 131.37, 132.90, 134.45, 134.68, 134.73, 142.32, 144.33, 171.59, 177.29, 178.59. ESI HRMS m/z 438.0513 ([M+Na]+ calcd 438.0509).
2-Dibenzoylamino-3-bromo-1,4-naphthoquinone (3b). Yellow solid. (53%). Mp: 234–238 °C. IR (cm−1) 3087, 1693, 1671, 1588, 1570. 1H-NMR (CDCl3) 7.30–7.34 (t, 4H, J = 7.40 Hz), 7.41–7.45 (tt, 2H, J = 1.21, 7.49 Hz), 7.77–7.81 (m, 6H), 8.10–8.12 (m, 1H), 8.20–8.22 (m, 1H). 13C-NMR (CDCl3) 127.72, 127.96, 128.58, 129.22, 130.65, 131.22, 132.89, 134.58, 134.68, 134.70, 138.75, 147.47, 171.55, 177.48, 178.30. ESI HRMS m/z 482.0005 ([M+Na]+ calcd 482.0004).
2-Dibenzoylamino-3-methoxy-1,4-naphthoquinone (3c). Yellow solid. (45%) Mp: 262–266 °C. IR (cm−1) 3012, 2953, 1675, 1651, 1605, 1578, 1270, 1249, 1218. 1H-NMR (CDCl3) 4.14 (s, 3H), 7.31–7.34 (dt, 4H, J = 1.60, 7.28 Hz), 7.41–7.45 (tt, 2H, J = 1.28, 7.44 Hz), 7.73–7.76 (m, 6H), 8.04–8.09 (m, 2H). 13C-NMR (CDCl3) 181.22, 180.43, 172.63, 154.71, 134.89, 134.55, 134.02, 132.61, 132.56, 131.67, 131.48, 130.86, 130.26, 129.04, 128.58, 128.54, 126.91, 126.73, 61.65. ESI HRMS m/z 434.0998 ([M+Na]+ calcd 434.1004).
2-Bis-(2-chlorobenzoyl)amino-3-chloro-1,4-naphthoquinone (3d). Yellow solid. (49%). Mp: 217–218 °C. IR (cm−1) 1720, 1681, 1618, 1588. 1H-NMR (CDCl3) 7.13–7.16 (d, 2H, J = 7.91 Hz), 7.21–7.25 (dt, 2H, J = 1.68, 7.51 Hz), 7.27–7.31 (dt, 2H, J = 1.30, 7.57), 7.79–7.85 (m, 2H), 7.87–7.89 (d, 2H, J = 4.75 Hz), 8.15–8.20 (m, 1H), 8.22–8.26 (m, 1H). 13C-NMR (CDCl3) 126.76, 126.93, 127.60, 127.80, 129.69, 130.54, 130.85, 131.37, 132.36, 132.52, 132.56, 132.75, 134.14, 134.75, 134.91, 142.65, 144.43, 177.13, 178.22. ESI HRMS m/z 505.9741 ([M+Na]+ calcd 505.9730).
2-Bis-(2-chlorobenzoyl)amino-3-bromo-1,4-naphthoquinone (3e). Yellow crystal (34%). Mp: 232–234 °C. IR (cm−1) 1728, 1688, 1671, 1588, 1468. 1H-NMR (CDCl3) 7.12–7.14 (d, 2H, J = 7.88 Hz), 7.19–7.23 (dd, 2H, J = 1.64, 7.56 Hz), 7.27–7.31 (dt, 2H, J = 1.28, 7.60 Hz), 7.80–7.85 (m, 2H), 7.93–7.94 (d, 2H, 5.2 Hz), 8.16–8.20 (m, 1H), 8.23–8.27 (m, 1H). 13C-NMR (CDCl3) 126.65, 127.66, 128.08, 129.63, 130.49, 130.81, 131.23, 132.25, 134.68, 134.80, 140.78, 145.81, 167.57, 177.26, 177.81. ESI HRMS m/z 549.9240 ([M+Na]+ calcd 549.9224).
2-Bis-(2-chlorobenzoyl)amino-3-methoxy-1,4-naphthoquinone (3f). Yellow solid. (64%) Mp: 195–200 °C. IR (cm−1) 3090, 2959, 1718, 1673, 1658, 1620, 1590, 1263, 1218, 1234, 1H-NMR (CDCl3) 4.30 (s, 3H), 7.19–7.28 (m, 6H), 7.73–7.80 (m, 4H), 8.07–8.12 (m, 2H). 13C-NMR (CDCl3) 180.88, 179.74, 168.21, 155.31, 134.30, 133.61, 132.08, 131.67, 131.10, 130.57, 130.16, 129.32, 128.67, 126.46, 126.27, 115.41, 103.74, 102.58, 61.47. ESI HRMS m/z 502.0224 ([M+Na]+ calcd 502.0225).
2-Bis-(3-chlorobenzoyl)amino-3-chloro-1,4-naphthoquinone (3g). Yellow solid. (31%). Mp: 258–260 °C. IR (cm−1) 3075, 1713, 1698, 1672, 1591, 1571. 1H-NMR (CDCl3) 7.27–7.31 (t, 2H, J = 7.85 Hz), 7.42–7.45 (ddd, 2H, J = 1.03, 2.09, 8.07 Hz), 7.60–7.63 (td, 2H, J = 1.07, 7.68 Hz), 7.70–7.71 (t, 2H, J = 1.82), 7.80–7.85 (m, 2H), 8.11–8.14 (m, 1H), 8.21–8.23 (m, 1H). 13C-NMR (CDCl3) 127.02, 127.93, 128.03, 129.34, 130.21, 130.75, 131.55, 133.29, 135.14, 135.21, 136.06, 143.00, 143.84, 170.20, 177.25, 178.66. ESI HRMS m/z 505.9741 ([M+Na]+ calcd 505.9730).
2-Bis-(3-chlorobenzoyl)amino-3-bromo-1,4-naphthoquinone (3h). Yellow solid (26%) Mp: 204–206 °C. IR (cm−1) 3074, 1698, 1671, 1589, 1566. 1H-NMR (CDCl3) 7.27–7.30 (t, 2H, J = 7.92 Hz), 7.41–7.44 (ddd, 2H, J = 1.04, 2.08, 8.04 Hz), 7.62–7.65 (td, 2H, J = 1.12, 7.72 Hz), 7.72–7.73 (t, 2H, J = 1.84 Hz), 7.78–7.85 (m, 2H), 8.10–8.14 (m, 1H), 8.20–8.24 (m, 1H). 13C-NMR (CDCl3) 127, 128.09, 128.40, 129.49, 130.25, 130.78, 131.49, 133.32, 135.15, 135.18, 135.24, 136.25, 139.56, 147.05, 170.21, 177.50, 178.43. ESI HRMS m/z 549.9236 ([M+Na]+ calcd 549.9224).
2-Bis-(3-chlorobenzoyl)amino-3-methoxy-1,4-naphthoquinone (3i). Yellow solid. (37%) Mp: 182–184 °C. IR (cm−1) 3107, 2960, 1707, 1689, 1670, 1657, 1604, 1572, 1283, 1266, 1239, 1218. 1H-NMR (CDCl3) 4.19 (s, 3H), 7.26–7.30 (t, 2H, J = 7.984 Hz), 7.40–7.43 (ddd, 2H, J = 1.04, 2.08, 8.04 Hz), 7.58–7.61 (td, 2H, J = 1.16, 7.72 Hz), 7.68–7.69 (t, 2H, J = 1.84 Hz), 7.73–7.77 (m, 2H), 8.05–8.09 (m, 2H). 13C-NMR (CDCl3) 180.66, 179.85, 170.63, 154.37, 135.97, 134.53, 134.35, 133.83, 132.37, 131.06, 130.29, 130.21, 129.58, 128.60, 126.58, 126.51, 126.32, 61.53. ESI HRMS m/z 502.0219 ([M+Na]+ calcd 502.0225).
2-Bis-(4-chlorobenzoyl)amino-3-chloro-1,4-naphthoquinone (3j). Yellow solid. (27%). Mp: 212–213 °C. IR (cm−1) 1737, 1714, 1696, 1673, 1589, 1571. 1H-NMR (CDCl3) 7.33–7.36 (td, 4H, J = 2.34, 8.54 Hz), 7.68–7.72 (td, 4H, J = 2.40, 8.47 Hz), 7.79–7.85 (m, 2H), 8 09–8.11 (dd, 1H, J = 2.50, 6.56 Hz), 8.20–8.22 (dd, 1H, J = 2.40, 6.66 Hz). 13C-NMR (CDCl3) 127.72, 127.80, 129.18, 130.34, 130.50, 131.32, 132.52, 134.92, 134.95, 139.67, 142.46, 143.87, 170.40, 177.05, 178.59. ESI MS m/z 505.975 ([M+Na]+ calcd 505.973).
2-Bis-(4-chlorobenzoyl)amino-3-bromo-1,4-naphthoquinone (3k). Yellow solid. (34%). Mp: 266–269 °C. IR (cm−1) 3096, 1703, 1661, 1586. 1H-NMR (CDCl3) 7.33–7.36 (td, 4H, J = 2.16, 8.47 Hz), 7.70–7.73 (td, 4H, J = 2.37, 8.53 Hz), 7.79–7.82 (m, 2H), 8.08–8.11 (m, 1H), 8.20–8.22(m, 1H). 13C-NMR (CDCl3) 127.80, 128.09, 129.13, 130.41, 130.46, 131.17, 132.66, 134.84, 134.90, 138.94, 139.61, 146.98, 170.32, 177.21, 178.28. ESI MS m/z 549.923 ([M+Na]+ calcd 549.9224).
2-Bis-(4-chlorobenzoyl)amino-3-methoxy-1,4-naphthoquinone (3l). Yellow solid. (64%) Mp: 170–172 °C. IR (cm−1) 3100, 2958, 1722, 1687, 1668, 1687, 1652, 1589, 1575, 1274. 1H-NMR (CDCl3) 4.15 (s, 3H), 7.32–7.35 (td, 4H, J = 2.36, 8.64 Hz), 7.66–7.70 (td, 4H, J = 2.36, 8.68 Hz), 7.74–7.76 (m, 2H), 8.05–8.08 (m, 2H). 13C-NMR (CDCl3) 181.11, 180.45, 171.50, 154.73, 139.32, 134.80, 134.32, 133.05, 131.52, 131.08, 130.75, 130.30, 129.19, 127.04, 126.97, 61.93. ESI HRMS m/z 502.0223 ([M+Na]+ calcd 502.0225).
2-Bis-(4-fluorobenzoyl)amino-3-chloro-1,4-naphthoquinone (3m). Yellow solid. (56%). Mp: 284–286 °C. IR (cm−1) 3074, 1719, 1689, 1672, 1591. 1H-NMR (CDCl3) 7.00–7.06 (tt, 4H, J = 2.85, 8.71 Hz), 7.75–7.85 (m, 6H), 8.10–8.12 (m, 1H), 8.20–8.22 (m, 1H). 13C-NMR (CDCl3) 116.08 (d, 2JF,C = 22.2 Hz, C-C-F), 116.41, 126.65, 126.96, 127.67, 127.77, 130.53, 130.57, 130.58, 131.35, 131.66 (d, 3JF,C = 9.4 Hz, C-C-C-F), 132.75, 134.88, 142.42, 144.13, 165.41(d, 1JF,C = 255.99 Hz, C-F), 170.33, 177.13, 178.63. ESI MS m/z 474.034 ([M+Na]+ calcd 474.032).
2-Bis-(4-fluorobenzoyl)amino-3-bromo-1,4-naphthoquinone (3n). Orange-yellow solid (66%). Mp: 170–172 °C. IR (cm−1) 1719, 1670, 1596, 1505. 1H-NMR (CDCl3) 7.03–7.07 (tt, 4H, J = 2.04, 8.68 Hz), 7.80–7.84 (m, 6H), 8.11–8.14 (m, 1H), 8.23–8.25 (m, 1H).13C-NMR (CDCl3) 115.68 (d, 2JF,C = 22.2 Hz, C-C-F), 127.4, 127.71, 130.18, 130.30, 130.33, 130.85, 131.39 (d, 3JF,C = 9.3 Hz, C-C-C-F), 131.44, 134.46, 134.50, 138.52, 146.90, 165.03 (d, 1JF,C = 255.92 Hz, C-F), 169.91, 176.96, 177.97. ESI HRMS m/z 517.9785 ([M+Na]+ calcd 517.9815).
2-Bis-(4-fluorobenzoyl)amino-3-methoxy-1,4-naphthoquinone (3o). Yellow solid. (14%) Mp: 177–179 °C. IR (cm−1) 3073, 3015, 2957, 1708, 1672, 1652, 1614, 1600, 1589, 1269. 1H-NMR (CDCl3) 8.09–8.04 (m, 2H), 7.78–7.74 (m, 6H), 7.03–7.01 (t, 4H, J = 8.56 Hz), 4.15 (s, 3H). 13C-NMR (CDCl3) 61.63, 115.82 (d, 2JF,C = 22.5 Hz, C-C-F), 126.70, 126.78, 130.60, 130.79, 130.82, 131.22, 131.30 (d, 3JF,C = 8.9 Hz, C-C-C-F), 131.31, 134.03, 134.52, 146.62, 154.51, 165.18 (d, 1JF,C = 255.2 Hz, C-F), 166.45, 171.20, 180.29, 180.95. ESI HRMS m/z 470.0807 ([M + Na]+ calcd 470.0816).
2-Bis-(4-tert-butylbenzoyl)amino-3-chloro-1,4-naphthoquinone (3p). Yellow solid.(28%). Mp: 257–260 °C. IR (cm−1) 2965, 2901, 2868, 1701, 1673, 1603, 1592, 1572. 1H-NMR (CDCl3) 1.25 (s, 18H), 7.30–7.32 (td, 4H, J = 1.81, 8.53 Hz), 7.67–7.69(td, 4H, J = 1.86, 8.57 Hz), 7.78–7.81 (m, 2H), 8.09–8.13 (m, 1H), 8.22–8.18 (m, 1H). 13C-NMR (CDCl3) 30.96, 35.06, 125.51, 127.60, 127.65, 129.14, 130.82, 131.45, 131.71, 134.62, 134.68, 142.09, 144.58, 156.57, 171.66, 177.51, 178.67. ESI HRMS m/z 550.1740 ([M+Na]+ calcd 550.1761).
2-Bis-(4-tert-butylbenzoyl)amino-3-bromo-1,4-naphthoquinone (3q). Yellow solid. (58%) Mp: 244–250 °C. IR (cm−1) 2965, 1699, 1674, 1604, 1270, 1186. 1H-NMR (CDCl3) 1.24 (s, 18H), 7.29–7.31 (d, 4H, J = 8.40 Hz), 7.68–7.70 (d, 4H, J = 8.4 Hz), 7.77–7.80 (m, 2H), 8.09–8.11 (m, 1H), 8.19–8.21 (m, 1H). 13C-NMR (CDCl3) 30.75, 34.85, 125.26, 127.52, 127.69, 129.03, 130.58, 131.10,m131.65, 134.36, 134.40, 138.26, 147.50, 156.30, 171.39, 177.46, 178.15. ESI HRMS m/z 1165.3845 ([dimer+Na]+ calcd 1165.2614).
2-Bis-(4-tert-butylbenzoyl)amino-3-methoxy-1,4-naphthoquinone (3r). Yellow solid. (37%) Mp: 222–224 °C. IR (cm−1) 2964, 2905, 2868, 1693, 1674, 1662, 1605, 1271, 1220, 1187. 1H-NMR (CDCl3) 1.25 (s, 18H), 4.12 (s, 3H), 7.30–7.32 (d, 4H, J = 8.44 Hz), 7.65–7.67 (d, 4H, J = 8.40 Hz), 7.71–7.75 (m, 2H), 8.04–8.10 (m, 2H). 13C-NMR (CDCl3) 30.97, 31.02, 34.98, 61.46, 125.35, 125.83, 126.53, 126.81, 128.87, 130.49, 130.87, 131.40, 131.96, 132.04, 133.81, 134.33, 154.64, 156.03, 172.52, 180.39, 181.22. ESI HRMS m/z 524.2449 ([M+Na]+ calcd 524.2437).
2-Bis-(4-methoxybenzoyl)amino-3-chloro-1,4-naphthoquinone (3s). Yellow solid. (48%). Mp: 283–287 °C. IR (cm−1) 3019, 1698, 1668, 1599, 1574, 1508. 1H-NMR (CDCl3).3.81 (s, 6H), 6.80–6.84 (td, 4H, J = 2.86, 8.95 Hz), 7.73–7.82 (m, 6H), 8.09–8.11 (m, 1H), 8.19–8.21 (m, 1H). 13C-NMR (CDCl3) 55.48, 113.98, 114.21, 126.76, 127.57, 127.64, 130.38, 130.79, 131.41, 131.48, 134.61, 134.66, 141.69, 144.95, 163.34, 171.03, 177.48, 178.77. ESI MS m/z 498.074 ([M+Na]+ calcd 498.072).
2-Bis-(4-methoxybenzoyl)amino-3-bromo-1,4-naphthoquinone (3t). Yellow solid. (70%). Mp: 205–210 °C. IR (cm−1) 2839, 1694, 1669, 1598, 1574, 1509, 1167. 1H-NMR (CDCl3). 3.80 (s, 6H), 6.80–6.82 (d, 4H, J = 8.48 Hz), 7.75–7.78 (m, 6H), 8.07–8.09 (m, 1H), 8.18–8.20 (m, 1H). 13C-NMR (CDCl3) 55.43, 113.89, 126.86, 127.67, 127.82, 130.70, 131.21, 131.52, 134.52, 134.54, 138.01, 148.01, 163.25, 170.92, 177.60, 178.40. ESI MS m/z 557.9965 ([M+K]+ calcd 557.9955).
2-Bis-(3,4,5-trimethoxybenzoyl)amino-3-chloro-1,4-naphthoquinone (3u). Orange crystals (51%). Mp: 171–172 °C. IR (cm−1) 3015, 2939, 2838, 1704, 1675, 1586, 1122. 1H-NMR (CDCl3) 3.81 (s, 12H), 3.84 (s, 6H), 7.02 (s, 4H), 7.81–7.84 (m, 2H), 8.12–8.14 (m, 1H), 8.22–8.24 (m, 1H). 13C-NMR (CDCl3) 56.27, 56.35, 60.93, 127.62, 127.77, 129.31, 130.69, 131.39, 134.86, 142.06, 142.27, 144.45, 153.01, 171.08, 177.27, 178.84. ESI MS m/z 618.118 ([M+Na]+ calcd 618.114).
2-N-(4-Chlorobenzoyl))-amino-3-chloro-1,4-naphthoquinone (4). 2-Amino-3-chloro-1,4-naphthoquinone (302 mg, 1.45 mmol) was dissolved in freshly distilled THF (15 mL). NaH (104 mg, 4.33 mmol) was added to the solution and the mixture was stirred at room temperature for 30 mins. p-Chlorobenzoyl chloride (0.27 mL, 2.14 mmol) was added and the mixture was stirred for 5 mins. THF was removed under vacuum and the mixture was extracted (see general experimental for work up). The crude was recrystallized in EtOH (20 mL) then triturated in ethyl acetate to obtain the 4 in 40% yield. IR (cm−1) 3330.36, 1693.64, 1659.97, 1609.37. 1H-NMR (CDCl3) 7.50–7.54 (td, J = 2.66, 8.45 Hz, 2H), 7.76–7.84 (m, 2H), 7.91–7.94 (td, J = 2.54, 8.58 Hz, 2H), 8.13–8.16 (dd, J = 1.86, 7.15 Hz, 1H), 8.22–8.24 (dd, J = 1.54, 7.46 Hz, 1H), 8.30 (s, 1H). 13C-NMR (DSMO-d6) 127.21, 127.30, 129.14, 129.91, 130.73, 131.57, 131.92, 132.68, 135.12, 137.16, 137.96, 142.11, 164.73, 177.93, 178.91. ESI HRMS m/z 346.0017 ([M+H]+ calcd 346.0038).
2-(N-Benzoyl-N-(4-chlorobenzoyl))-amino-3-chloro-1,4-naphthoquinone (5). Compound 4 (101 mg, 0.292 mmol) was dissolved in THF (15 mL). NaH (14 mg, 0.583 mmol) was added followed by benzoyl chloride (0.07 mL, 0.604 mmol). The resulting mixture was stirred at room temperature for 26 hours. THF was removed under vacuum and the mixture was extracted (see general experiment for work up). The crude was purified by column chromatography with silica gel in CH2Cl2 to obtain a yellow solid in 43% yield. IR (cm−1) 3093, 1705, 1693, 1673, 1587, 1571, 1521. 1H-NMR (CDCl3) 7.30–7.33 (td, 2H, J = 1.89, 6.72 Hz), 7.33–7.37 (t, J = 7.98 Hz, 2H), 7.45–7.47 (t, 1H, J = 7.46 Hz), 7.69–7.72 (td, 2H, J = 1.96, 8.60 Hz), 7.73–7.76 (td, 2H, J = 1.41, 8.49 Hz), 7.79–7.82 (m, 1H), 8.10–8.13 (m, 1H), 8.20–8.22 (m, 1H). 13C-NMR (CDCl3) 127.68, 127.73, 128.76, 129.00, 129.06, 130.63, 131.37, 133.21, 134.82, 124.84, 171.34, 177.19, 178.60. ESI MS m/z 472.0097 ([M+Na]+ calcd 472.0119).
2-N-acteylamino-3-chloro-1,4-naphthoquinone (6). 2-Amino-3-chloro-1,4-naphthoquinone (305 mg, 1.47 mmol) was stirred for 10 mins at room temperature in acetic anhydride (9 mL, 95.39 mmol). Conc. sulfuric acid (1 drop) was added and the reaction mixture was stirred to obtain a yellow precipitate in 64% yield. IR (cm−1) 3308.59, 1711.06, 1607.38, 1586.41, 1475.28, 1198.03. 1H-NMR (CDCl3) 2.32 (s, 3H), 7.68 (s, 1H), 7.76–7.83 (m, 2H), 8.12–8.15 (ddd, 1H, J = 1.88, 2.20, 7.20 Hz), 8.20–8.22 (ddd, 1H, J = 1.44, 2.68, 7.08 Hz). 13C-NMR (CDCl3) 24.18, 127.09, 127.57, 130.26, 131.58, 134.16, 134.83. MALDI MS m/z 273.1471 ([M+Na]+ calcd 272.0090).
2-(N-acetyl-N-(4-chlorobenzoyl))-amino-3-chloro-1,4-naphthoquinone (7). Compound 6 (300 mg, 1.2 mmol) was dissolved in THF (26 mL). NaH (75.6 mg, 1.88 mmol) was added to the solution and the mixture was stirred at room temperature for 15 min. 4-Chlorobenzoyl chloride (0.2 mL, 1.56 mmol) was added and the mixture was stirred at room temperature for 25 hrs. THF was removed under vacuum and the mixture was extracted (see general experiment for work up). The crude was purified by triturating in 50% ether/hexane mixture, followed by recrystallization from hexane (1.2 mg of crude/mL of hexane) to obtain a yellow solid in 41% yield. Mp: 134–136 °C. IR (cm−1) 1673.43, 1702.76, 1591.38, 1254.29, 1197.10. 1H-NMR (CDCl3) 2.56 (s, 3H), 7.31–7.35 (td, 2H, J = 2.32, 8.72 Hz), 7.59–7.62 (td, 2H, J = 2.36, 8.52 Hz), 7.79–7.82 (m, 2H), 8.11–8.16 (m, 2H). 13C-NMR (CDCl3) 25.33, 127.67, 129.02, 129.54, 130.54, 131.16, 132.67, 134.76, 134.84, 139.39, 143.32, 143.42, 169.66, 171.94, 176.85, 178.48. ESI MS m/z 410.0009 ([M+Na]+ calcd 409.9963). Structural information of compound 7 has been deposited with the CCDC as CCDC894544. This data is available free of charge from www.ccdc.com.ac.uk/conts/rtrieving.html (or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 IEZ, UK).

4. Conclusions

In conclusion, we have synthesized a series of novel symmetrical and unsymmetrical 3-halo- or 3-methoxy- substituted 2-imido-1,4-naphthoquinone analogs (with an average yield of 45%) via sodium hydride promoted bis-acylation of 3-halo-/3-methoxy-substituted 2-amino-1,4-naphthoquinone derivatives. These imido-naphthoquinone analogs were charaterized by electrospray ionization mass spectrometric studies, infrared, 1H-NMR and 13C-NMR spectroscopic techniques. X-ray crystallographic studies of an unsymmeterical analog showed the imide group is oriented almost perpendicular to the plane of the naphthoquinone ring and the two imide carbonyls are anti to each other.

Acknowledgments

This work was supported in part by grant number 5-U54-CA914-31 (Howard University/Johns Hopkins Cancer Center Partnership); in part by grant G12MD007597 from the National Institute On Minority Health and Health Disparities of the National Institutes of Health; and in part by MRI grant number CHE-1126533 from the NSF.
  • Sample Availability: Not available.

References

  1. Xu, K.; Xiao, Z.; Tang, Y.B.; Huang, L.; Chen, C.-H.; Ohkoshi, E.; Lee, K.-H. Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors. Bioorg. Med. Chem. Lett. 2012, 22, 2772–2774. [Google Scholar]
  2. Ashe, C. Antitumor quinones. Med. Chem. 2005, 5, 449–467. [Google Scholar]
  3. Garuti, L.; Roberti, M.; Pizzirani, D. Nitrogen-containing heterocyclic quinones: A class of potential selective antitumor agents. Med. Chem. 2007, 7, 481–489. [Google Scholar]
  4. Hadden, M.K.; Hill, S.A.; Davenport, J.; Matts, R.L.; Blagg, B.S. Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthquinoe scaffold. Bioorg. Med. Chem. 2009, 17, 634–640. [Google Scholar] [CrossRef]
  5. Lavergne, O.; Fernandes, A.; Brehu, L.; Sidhu, A.; Brezak, M.; Prevost, G.; Ducommun, B.; Contour-Galcera, M. Synthesis and biological evaluation of novel heterocyclic quinines as inhibitors of the dual specificity protein phosphatase CDC25C. Bioorg. Med. Chem. 2006, 16, 171–175. [Google Scholar] [CrossRef]
  6. Brun, M.; Braud, E.; Angotti, D.; Mondesert, O.; Quaranta, M.; Montes, M.; Miteva, M.; Gresh, N.; Ducommun, B.; Garbay, C. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity. Bioorg. Med. Chem. 2005, 13, 4871–4879. [Google Scholar] [CrossRef]
  7. Han, Y.; Shen, H.; Carr, B.I.; Wipf, P.; Lazo, J.S.; Pan, S. NAD(P)H: Quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors. J. Pharmacol. Exp. Ther. 2004, 309, 64–70. [Google Scholar] [CrossRef]
  8. Kumar, S.; Malachowski, W.P.; DuHadaway, J.B.; LaLonde, J.M.; Carroll, P.J.; Jaller, D.; Metz, R.; Prendergast, G.C.; Muller, A.J. Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. J. Med. Chem. 2008, 51, 1706–1718. [Google Scholar] [CrossRef]
  9. Lee, J.H.; Cheong, J.; Park, Y.; Choi, Y.H. Down-regulation of cyclooxygenase-2 and telomerase activity by β-lapachone in human prostate carcinoma cells. Pharm. Res. 2005, 51, 553–560. [Google Scholar] [CrossRef]
  10. Lu, Q.; Liu, W.; Ding, J.; Cai, J.; Duan, W. Shikonin derivatives: Synthesis and inhibition of human telomerase. Bioorg. Med. Chem. Lett. 2002, 12, 1375–1378. [Google Scholar] [CrossRef]
  11. Acharya, B.R.; Bhattacharyya, B.; Chakrabarti, G. The natural naphthoquinone plumbagin exhibits antiproliferative activity and disrupts the microtubule network through tubulin binding. Biochemistry 2008, 47, 7838–7845. [Google Scholar] [CrossRef]
  12. Acharya, B.R.; Choudhury, D.; Das, A.; Chakrabarti, G. Vitamin K3 disrupts the microtubule networks by binding to tubulin: A novel mechanism of its anti-proliferative activity. Biochemistry 2009, 48, 6963–6974. [Google Scholar] [CrossRef]
  13. Cai, W.; Hassani, M.; Karki, R.; Walter, E.D.; Koelsch, K.H.; Seradj, H.; Lineswala, J.P.; Mirzaei, H.; York, J.S.; Olang, F.; et al. Synthesis, Metabolism and in vitro cytotoxicity studies on novel Lavendamycin antitumor agents. Bioorg. Med. Chem. 2010, 18, 1899–1909. [Google Scholar] [CrossRef]
  14. Tudor, G.; Gutierrez, P.; Aguilera-Gutierrez, A.; Sausville, E. Cytoxocitiy and apoptosis of benzoquinones: Redox cycling, cytochrome c release, and BAD protein expression. Biochem. Pharm. 2002, 65, 1061–1075. [Google Scholar]
  15. Bakare, O.; Ashendel, C.L.; Peng, H.; Zalkow, L.H.; Burgess, E.M. Synthesis and MEK1 inhibitory activities of imido-substituted 2-Chloro-1,4-naphthoquinone. Bioorg. Med. Chem. 2003, 11, 3165–3170. [Google Scholar] [CrossRef]
  16. Berhe, S.; Kanaan, Y.; Copeland, R.L.; Wright, D.A.; Zalkow, L.H.; Bakare, O. Microwave-assisted synthesis of imido-substituted 2-chloro-1,4-naphthoquinone derivatives and their cytotoxic activities on three human prostate cancer cell lines. Lett. Drug Des. Discov. 2008, 5, 485–488. [Google Scholar] [CrossRef]
  17. Copeland, R.L., Jr.; Das, J.R.; Bakare, O.; Enwerem, N.M.; Berhe, S.; Hillaire, K.; White, D.; Beyene, D.; Kassim, K.; Kanaan, Y. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and independent prostate cancer cell lines. Anticancer Res. 2007, 27, 1537–1546. [Google Scholar]
  18. Kanaan, Y.; Das, J.R.; Bakare, O.; Enwerem, N.M.; Berhe, S.; Beyene, D.; Williams, V.; Zhou, Y.; Copeland, R.L., Jr. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent. Anticancer Res. 2009, 29, 191–200. [Google Scholar]
  19. Berhe, S.; Slupe, A.; Luster, C.; Charlier, H.A.; Warner, D.L.; Zalkow, L.H.; Burgess, E.M.; Enwerem, N.M.; Bakare, O. Synthesis of 3-[(N-Carboalkoxy)ethylamino]-indazole-dione derivatives and their biological activities on human liver carbonyl reductase. Bioorg. Med. Chem. 2010, 18, 134–141. [Google Scholar] [CrossRef]
  20. Brandy, Y.; Ononiwu, I.; Adedeji, D.; Williams, V.; Mouamba, C.; Kanaan, Y.; Copeland, R.L.; Wright, D.A.; Butcher, R.J.; Denmeade, S.R.; Bakare, O. Synthesis and cytotoxic activities of some2-Arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines. Invest. New Drugs 2012, 30, 1709–1714. [Google Scholar] [CrossRef]
  21. Khraiwesh, H.M.; Lee, C.M.; Brandy, Y.; Akinboye, E.S.; Berhe, S.; Gittens, G.; Abbas, M.M.; Ampy, F.R.; Ashraf, M.; Bakare, O. Antitrypanosomal activities and cytotoxicity of some novel imido-substituted 1,4-naphthoquinone derivatives. Arch. Pharm. Res. 2012, 35, 27–33. [Google Scholar] [CrossRef]
  22. Lien, J.; Huang, L.; Wang, J.; Teng, C.; Lee, K.; Kuo, S. Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents. Chem. Pharm. Bull. 1996, 44, 1181–1187. [Google Scholar] [CrossRef]
  23. Kuo, S.; Ibuka, T.; Huang, L.; Lien, J.; Yean, S.; Huang, S.; Lednicer, D.; Morris-Natschke, S.; Lee, K. Synthesis and cytotoxicity of 1,2-disubstituted naphth[2,3-d]imidazole-4,9-diones and related compounds. J. Med. Chem. 1996, 39, 1447–1451. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Brandy, Y.; Brandy, N.; Akinboye, E.; Lewis, M.; Mouamba, C.; Mack, S.; Butcher, R.J.; Anderson, A.J.; Bakare, O. Synthesis and Characterization of Novel Unsymmetrical and Symmetrical 3-Halo- or 3-Methoxy-substituted 2-Dibenzoylamino-1,4-naphthoquinone Derivatives. Molecules 2013, 18, 1973-1984. https://doi.org/10.3390/molecules18021973

AMA Style

Brandy Y, Brandy N, Akinboye E, Lewis M, Mouamba C, Mack S, Butcher RJ, Anderson AJ, Bakare O. Synthesis and Characterization of Novel Unsymmetrical and Symmetrical 3-Halo- or 3-Methoxy-substituted 2-Dibenzoylamino-1,4-naphthoquinone Derivatives. Molecules. 2013; 18(2):1973-1984. https://doi.org/10.3390/molecules18021973

Chicago/Turabian Style

Brandy, Yakini, Nailah Brandy, Emmanuel Akinboye, Malik Lewis, Claudia Mouamba, Seshat Mack, Ray J. Butcher, Alan J. Anderson, and Oladapo Bakare. 2013. "Synthesis and Characterization of Novel Unsymmetrical and Symmetrical 3-Halo- or 3-Methoxy-substituted 2-Dibenzoylamino-1,4-naphthoquinone Derivatives" Molecules 18, no. 2: 1973-1984. https://doi.org/10.3390/molecules18021973

APA Style

Brandy, Y., Brandy, N., Akinboye, E., Lewis, M., Mouamba, C., Mack, S., Butcher, R. J., Anderson, A. J., & Bakare, O. (2013). Synthesis and Characterization of Novel Unsymmetrical and Symmetrical 3-Halo- or 3-Methoxy-substituted 2-Dibenzoylamino-1,4-naphthoquinone Derivatives. Molecules, 18(2), 1973-1984. https://doi.org/10.3390/molecules18021973

Article Metrics

Back to TopTop